Company profile
Axelyf
Developing next-generation lipid nanoparticle delivery systems to unlock the potential of RNA therapeutics
- Industry
- Biotechnology Research
- Employees
- 15
- Headquarters
- Brookline, MA
- Founded
- 2022
- LinkedIn followers
- 1,072
- Office locations
- 2
Axelyf company summary
Axelyf is a company in the Biotechnology Research industry, headquartered in Brookline, MA, founded in 2022. On LinkedIn the company has around 15 employees and 1,072 followers. The company lists 2 office locations.
What technology does Axelyf use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Axelyf
Axelyf is a biotechnology company developing and delivering medicines based on RNA and using best-in-class proprietary lipid nanoparticle technology, leveraging the AXL library. The technology is targetable for extrahepatic delivery of RNA payloads with potency, tolerability and selectivity for numerous applications in medicines. Our background is drug development and we are establishing a therapeutic focus initially in autoimmune treatments, where the premium on delivery is significant. Our legacy prodrug product, BPH-555, is a complementary asset in autoimmune disease based on the natural lipid Astaxanthin. Our prodrug is orally active and a strong anti-inflammatory in the CIA model, matching the performance of a billion-dollar JAK inhibitor Tofacitinib (XELJANZ). BPH-555 is superior in oral bioavailability to astaxanthin oil supplements, and with its improved properties is the best candidate for pharmaceutical development and commercialization of a drug delivering astaxanthin. The program is supported by grants, ready for IND-enabling studies in 2026, and targeted for partnering as we focus on the RNA-LNP enabling approach to generate new medicines.
Where is Axelyf located?
Axelyf lists 2 office locations.
Compare companies similar to Axelyf
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Axelyf axelyf.com | Biotechnology Research | 15 | 2022 | Brookline, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Axelyf
What does Axelyf do?
Axelyf is a biotechnology company developing and delivering medicines based on RNA and using best-in-class proprietary lipid nanoparticle technology, leveraging the AXL library. The technology is targetable for extrahepatic delivery of RNA payloads with potency, tolerability and selectivity for numerous applications in medicines. Our background is drug development and we are establishing a therapeutic focus initially in autoimmune treatments, where the premium on delivery is significant. Our legacy prodrug product, BPH-555, is a complementary asset in autoimmune disease based on the natural lipid Astaxanthin. Our prodrug is orally active and a strong anti-inflammatory in the CIA model, matching the performance of a billion-dollar JAK inhibitor Tofacitinib (XELJANZ). BPH-555 is superior in oral bioavailability to astaxanthin oil supplements, and with its improved properties is the best candidate for pharmaceutical development and commercialization of a drug delivering astaxanthin. The program is supported by grants, ready for IND-enabling studies in 2026, and targeted for partnering as we focus on the RNA-LNP enabling approach to generate new medicines.
How many employees does Axelyf have?
Axelyf has around 15 employees on LinkedIn.
Where is Axelyf headquartered?
Axelyf is headquartered in Brookline, MA.
Where does Axelyf have offices?
Axelyf lists 2 office locations, including Brookline, MA, US; Hafnarfjörður, Capital Region 220, IS.
When was Axelyf founded?
Axelyf was founded in 2022.
Build a lead list from companies like Axelyf
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.